Skip to content

HIV RNA Viral Load (Quantitative) with Probe-Based Detection

Published: August 9, 2026Updated: August 16, 2026

This test measures the amount of HIV RNA in your blood, helping doctors track how well your treatment is working and monitor disease progression.

Quick summary

["HIV RNA levels help guide treatment decisions and assess viral suppression."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
85361-4
Short code
HIV1+2 RNA Bld Ql NAA+probe
Synonyms
HIV1+2 RNA Bld Ql NAA+probe
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
probe-amp-tar
CPT
86701
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your healthcare provider may order this test if you have HIV to check how well your current treatment is controlling the virus. It’s also used during pregnancy to monitor viral load or before starting new treatments. Sometimes, it’s done as part of routine follow-up care to ensure the virus remains undetectable.

How the Test Works

The test uses a specialized probe to detect and measure the genetic material (RNA) of HIV in your blood sample. This method is highly sensitive and can detect very low levels of the virus, even when it’s suppressed by treatment.

Sample Collection and Preparation

A blood sample is drawn from a vein, usually in your arm. The blood is then processed to separate the plasma or serum, which contains the viral RNA. This is sent to a lab for testing.

What to Expect Before the Test

No special preparation is needed, but you may want to avoid alcohol or strenuous activity before the blood draw. If you’re pregnant, breastfeeding, or have certain medical conditions, let your provider know.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

High HIV RNA levels (above 50 copies/mL or 1,000 IU/mL) often mean the virus isn’t well-controlled by treatment and may require adjustments. Low or undetectable levels (below 50 copies/mL or 1,000 IU/mL) suggest the virus is suppressed, which is a key goal of HIV treatment. Regular testing helps prevent resistance to medications and ensures long-term health.

Short name

HIV RNA Load

Frequently asked questions

What Does an Abnormal Result Mean?
An abnormal result—meaning a higher-than-normal viral load—could indicate treatment failure, drug resistance, or the need for a different medication. Your provider will discuss next steps, such as adjusting your treatment plan or retesting.
How Often Should I Get This Test?
The frequency depends on your treatment and health status. Typically, people on effective HIV treatment may test every 3–6 months. Pregnant women or those with unstable viral loads may need more frequent testing.
Can Diet or Exercise Affect This Test?
No, diet or exercise typically do not affect HIV RNA levels. The test measures the virus itself, not your immune system or overall health. However, always follow your provider’s instructions for timing around blood draws.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy